J3D3

New Antibiotic Resistance Genes Found

ArticlePress release
Current Medical News
Contributed byMaulik P. Purohit MD MPHOct 17, 2017

Researchers at Chalmers University of Technology and the University of Gothenburg, Sweden, have found several previously unknown genes that make bacteria resistant to last-resort antibiotics. The genes were found by searching large volumes of bacterial DNA and the results are published in the scientific journal Microbiome.

The increasing number of infections caused by antibiotic-resistant bacteria is a rapidly growing global problem. Disease-causing bacteria become resistant through mutations of their own DNA or by acquiring resistance genes from other, often harmless, bacteria.

By analysing large volumes of DNA data, the researchers found 76 new types of resistance genes. Several of these genes can provide bacteria with the ability to degrade carbapenems, our most powerful class of antibiotics used to treat multi-resistant bacteria.

"Our study shows that there are lots of unknown resistance genes. Knowledge about these genes makes it possible to more effectively find and hopefully tackle new forms of multi-resistant bacteria," says Erik Kristiansson, Professor in biostatistics at Chalmers University of Technology and principal investigator of the study.

"The more we know about how bacteria can defend themselves against antibiotics, the better are our odds for developing effective, new drugs," explains co-author Joakim Larsson, Professor in environmental pharmacology and Director of the Centre for Antibiotic Resistance Research at the University of Gothenburg.

The researchers identified the novel genes by analysing DNA sequences from bacteria collected from humans and various environments from all over the world.

"Resistance genes are often very rare, and a lot of DNA data needs to be examined before a new gene can be found," Kristiansson says.

Identifying a resistance gene is also challenging if it has not previously been encountered. The research group solved this by developing new computational methods to find patterns in DNA that are associated with antibiotic resistance. By testing the genes they identified in the laboratory, they could then prove that their predictions were correct.

"Our methods are very efficient and can search for the specific patterns of novel resistance genes in large volumes of DNA sequence data," says Fanny Berglund, a PhD student in the research group.

The next step for the research groups is to search for genes that provide resistance to other forms of antibiotics.

"The novel genes we discovered are only the tip of the iceberg. There are still many unidentified antibiotic resistance genes that could become major global health problems in the future," Kristiansson says.


Materials provided by Chalmers University of TechnologyNote: Content may be edited for style and length.

Disclaimer: DoveMed is not responsible for the accuracy of the adapted version of news releases posted to DoveMed by contributing universities and institutions.

References:

Fanny Berglund, Nachiket P. Marathe, Tobias Österlund, Johan Bengtsson-Palme, Stathis Kotsakis, Carl-Fredrik Flach, D G Joakim Larsson, Erik Kristiansson. (2017). Identification of 76 novel B1 metallo-β-lactamases through large-scale screening of genomic and metagenomic dataMicrobiome. DOI: 10.1186/s40168-017-0353-8

Was this article helpful

On the Article

Maulik P. Purohit MD MPH picture
Approved by

Maulik P. Purohit MD MPH

Assistant Medical Director, Medical Editorial Board, DoveMed Team

0 Comments

Please log in to post a comment.

Related Articles

Test Your Knowledge

Asked by users

Related Centers

Loading

Related Specialties

Loading card

Related Physicians

Related Procedures

Related Resources

Join DoveHubs

and connect with fellow professionals

Related Directories

Who we are

At DoveMed, our utmost priority is your well-being. We are an online medical resource dedicated to providing you with accurate and up-to-date information on a wide range of medical topics. But we're more than just an information hub - we genuinely care about your health journey. That's why we offer a variety of products tailored for both healthcare consumers and professionals, because we believe in empowering everyone involved in the care process.
Our mission is to create a user-friendly healthcare technology portal that helps you make better decisions about your overall health and well-being. We understand that navigating the complexities of healthcare can be overwhelming, so we strive to be a reliable and compassionate companion on your path to wellness.
As an impartial and trusted online resource, we connect healthcare seekers, physicians, and hospitals in a marketplace that promotes a higher quality, easy-to-use healthcare experience. You can trust that our content is unbiased and impartial, as it is trusted by physicians, researchers, and university professors around the globe. Importantly, we are not influenced or owned by any pharmaceutical, medical, or media companies. At DoveMed, we are a group of passionate individuals who deeply care about improving health and wellness for people everywhere. Your well-being is at the heart of everything we do.

© 2023 DoveMed. All rights reserved. It is not the intention of DoveMed to provide specific medical advice. DoveMed urges its users to consult a qualified healthcare professional for diagnosis and answers to their personal medical questions. Always call 911 (or your local emergency number) if you have a medical emergency!